Loading
Life sciences · Journal article
Acupuncture & Electro-therapeutics Research · September 17, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Breast cancer is a highly malignant tumor, and the incidence rate of bone metastasis is high. Electroacupuncture (EA) therapy has also shown therapeutic effects in reducing cancer-related symptoms and regulating bone metabolism. However, AE therapy combined with exercise intervention (EA-EX) has not been investigated in breast cancer bone metastasis. Methods The pathological changes in bone tissues were observed through hematoxylin/eosin staining and tartrate-resistant acid phosphatase staining. The protein expressions of genes were tested through Western blot. The N 6 -methyladenosine level was determined through a commercial kit. The interaction between mastermind-like transcriptional coactivator 2 (MAML2) and YTH domain family member 1 (YTHDF1) was examined through RNA immunoprecipitation assay. The fluorescent intensity was verified through luciferase reporter assay. Results EA-EX treatment alleviated breast cancer bone metastasis by reducing bone destruction. Moreover, EA-EX treatment regulated the YTHDF1–MAML2–wingless-related integration site (Wnt) axis. Further experiments revealed that MAML2 promoted osteoclast differentiation. Finally, YTHDF1 was shown to interact with MAML2 and suppress the Wnt/β-catenin signaling pathway. Conclusion These results demonstrate that EA-EX may regulate the YTHDF1–MAML2–Wnt axis, which may provide a new therapeutic strategy for inhibiting breast cancer bone metastasis.